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Abstract
Articular cartilage has a poor reparative capacity. This feature is exacerbated with aging and during degenerative joint conditions,
contributing to loss of motion and impairment of quality of life. This study focused on osteogenic protein-1 (OP-1) and its ability to serve as a
repair-stimulating factor in articular cartilage. The purpose of this work was to develop a quantitative method for the assessment of the content of
OP-1 protein in extracts from human articular cartilage and to investigate the changes in OP-1mRNA expression and protein levels with aging of
normal adult cartilage. Full thickness cartilage was dissected from femoral condyles of donors with no history of joint disease within 24 h of
death. Levels of OP-1 mRNA expression were measured by a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR)
method; concentration of OP-1 protein was detected by new sandwich enzyme-linked immunosorbent assay (ELISA); qualitative changes in
OP-1 forms were evaluated by Western blots with various anti-OP-1 antibodies. The sensitivity of the ELISA method allowed the detection of
picogram quantities of OP-1 in cartilage extracts. We found that (1) concentration of OP-1 in normal cartilage is within the range of biological
activity of OP-1 in vitro; and (2) during aging of human adult, articular cartilage, levels of OP-1 protein and message are dramatically reduced
(more than 4-fold; p < 0.02). The major qualitative changes affected primarily mature OP-1. The results of the current study suggest the
possibility that OP-1 may be critical for chondrocytes to maintain their normal homeostasis and could also serve as a repair factor during joint
disease or aging.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Osteoarthritis (OA) is a debilitating joint disease affect-
ing primarily the elderly. OA is rare in young adults,
developing symptomatically and radiographically in adults
by their late 40s and 50s, and then, rapidly increases in
prevalence from age 60 to 70 [1]. However, the mechanisms
that turn normal aging of articular cartilage into the patho-
logical OA process are currently unknown. In general, as
any biological tissue or organ ages, function gradually
declines and susceptibility to disease and injury increases
[2]. During the last decade, a number of age-related changes
in cartilage have been documented: (1) an increased dena-
turation of collagen type II [3]; (2) a decline in synthesis of
DNA [4], proteoglycans (PG) and link protein [5–8]; (3) an
increased sulfation of chondroitin sulfate [9]; (4) accumu-
lation of hyaluronan [10] and cartilage intermediate layer
protein [11]; (5) structural changes in fibromodulin [12]; (6)
a decreased capability of assembling large molecular size
aggregates [7]; (7) elevated levels of transglutaminase
activity that promotes a pathologic matrix mineralization
and cartilage degeneration [13]; and (8) increased apoptosis
[14]. Importantly, with aging, the responsiveness of articular
cartilage to different growth factors, such as transforming
growth factor-h (TGF-h) [6,15], insulin-like growth factor-1
(IGF-1) [16], epidermal growth factor (EGF) [4], osteogenic
protein-1 (OP-1) [17] and others, was also changed.
While the underlying causes of articular cartilage degen-
eration seen with age have not been identified, there is
increasing evidence that cytokines and growth factors,
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especially those expressed endogenously in cartilage, play a
critical mediatory role. Since growth factors, and particu-
larly members of the bone morphogenetic protein family
(BMP), are important regulators of matrix production that
can also inhibit certain degradative processes, it is not dif-
ficult to envision how a loss in the biologically active endo-
genous growth factor could play a role in the development
of matrix damage.
BMPs were originally identified as proteins capable of
inducing ectopic endochondral bone formation in subcuta-
neous implants [18,19]. Subsequent molecular cloning
revealed that the BMP family consists of a large number of
related molecules that belong to the TGF-h superfamily.
Although BMPs were initially found in the bone matrix, it
is now clear that they are expressed in a variety of tissues. OP-
1 is the seventh member of this family (BMP-7). It is
synthesized as a large precursor, approximately three times
larger than a mature protein, and is ultimately processed
proteolytically at the C-terminal region to yield a mature
disulfide-linked dimer. OP-1 is the most closely related to
BMP-6 and BMP-5 (88% and 87% homology), and to a lesser
extent to BMP-2 and BMP-4 (60% and 58%), with some
homology to BMP-3 (42%) and TGF-h (about 30%) [20,21].
Originally, OP-1 was purified from bovine demineralized
bone [22] with its recombinant form being subsequently
cloned from human cDNA libraries in Chinese hamster ovary
(CHO) cells [23]. The critical importance of BMPs for
cartilage and bone formation was demonstrated using the
transgenic approach: lack of some BMP genes caused skel-
etal abnormalities and eventually the lethality of mouse
embryos [24,25]. Recent studies from our department
[17,26–28] have focused on the potential role of exogenous
OP-1 in human and bovine cartilage homeostasis and repair.
We showed that human recombinant OP-1 caused a signifi-
cant anabolic response in articular cartilage. It induced the
synthesis of major matrix components (aggrecan and colla-
gen type II) in human chondrocytes of different age [17,26]
with continued expression of the chondrocyte phenotype. In
addition, OP-1 has been shown to induce the synthesis of
hyaluronan, its receptor CD44 and hyaluronan synthase-2, to
promote the formation and retention of the extracellular
matrix [28], and to counteract catabolic events, such as
interleukin-1 (IL-1), fibronectin and collagen fragment-
induced human cartilage degeneration [26,27,29]. When the
effect of OP-1 on the Fn-f-challenged cartilage was compared
to that of TGF-h, it was found that TGF-h was not able to
block Fn-f-mediated PG depletion, but by itself promoted a
decrease in cartilage PG content [27]. Importantly, recombi-
nant OP-1 did not lead to chondrocyte proliferation and
differentiation in human and bovine adult articular cartilage
during short-term culture [17,30].
Noteworthy, we previously showed [31] that OP-1 is
endogenously expressed by human adult articular chondro-
cytes. Moreover, in human articular cartilage, OP-1 is
present in two forms, unprocessed, pro-form, and processed,
mature-form, that are distributed in the inverted manner.
Mature OP-1 is immunolocalized primarily in the superficial
layer of cartilage, while pro-OP-1 is detected in the deep
layer. The endogenous expression of OP-1 by articular
chondrocytes indicates that articular cartilage has the poten-
tial to repair and might suggest the unique role of this BMP
in tissue protection and regeneration. This is supported by
recent data [32] where overexpression of OP-1 in mice led
to the increased synthesis of matrix macromolecules, colla-
gen type II and PGs.
The purpose of the current study was to investigate
changes in endogenous OP-1 (protein and mRNA) with
aging of human articular cartilage. We hypothesized that
with aging, there will be a decline in the levels of endoge-
nous OP-1, primarily, mature form of the protein, that might
contribute to the elevated susceptibility of cartilage to the
degenerative processes. To assess quantitatively the concen-
tration of total endogenous OP-1 protein in cartilage extracts,
we developed a sandwich OP-1 enzyme-linked immuno-
sorbent assay (ELISA). We present here a quantitative data
on age-related changes in endogenous OP-1 mRNA and
protein and provide a qualitative analysis of these changes.
2. Materials and methods
2.1. Reagents
Human recombinant pro- and mature-OP-1, BMP-6, anti-
pro (R2854) and anti-mature (1B12) OP-1 antibodies were
provided by Stryker Biotech (Hopkinton, MA). Two other,
anti-mature OP-1 antibodies (sc-9305 and MAB 354) were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA)
and R&D Systems (Minneapolis, MN). Electrophoresis
grade reagents were purchased from Bio-Rad (Hercules,
CA). Chemicals, either reagent or molecular biology grade,
were purchased from Sigma (St. Louis, MO) unless other-
wise noted. Keratanase (Ker; Pseudomonas sp.; EC 3.2.1.
103), keratanase II (Ker II; Bacillus sp. Ks 36) and chon-
droitinase ABC (CHase; Proteus vulgaris; EC 4.2.2.2) were
obtained from Seikagaku, Japan. Hyaluronidase (bovine
testicular) was purchased from Sigma and Collagenase P
(Clostridium histolyticus) was purchased from Boehringer
Mannheim.
2.2. Tissue acquisition
Full thickness normal human articular cartilage was
dissected from load bearing regions of femoral condyles
of donors with no history of joint disease within 24 h of
death. Samples from men and women ranging from 20 to 80
years old were obtained, with institutional approval, through
the Regional Organ Bank of Illinois according to their
protocol. After opening the joint, the surface of the cartilage
was grossly examined. Although all cartilages were
obtained from normal donors, not all of them appeared to
be normal. Some samples revealed degenerative morpho-
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logical changes. All cartilages were processed for either
messenger RNA or protein extraction.
2.3. OP-1 antibodies
We used four different antibodies for this study. Anti-
bodies obtained from Stryker Biotech (R2854 and 1B12)
were previously described and specificity toward OP-1 was
tested [31,33–35]. The polyclonal antibody R2854 was
raised in rabbits against the monomeric pro-domain of the
OP-1 molecule. For the detection of the mature domain of
OP-1, we utilized three antibodies that were available to us
either from commercial sources or from Stryker Biotech.
Two monoclonal antibodies, 1B12 and MAB354, were
raised against the monomeric mature domain of OP-1. A
third, polyclonal antibody sc-9305 was raised against a 15-
amino-acid synthetic peptide within the N-terminus of the
mature OP-1 domain. The specificity of all antibodies was
tested by the companies that produced these antibodies.
However, taking into consideration the high homology
between OP-1 and BMP-6 and the fact that the recombinant
BMP-6 was cloned after the anti-OP-1 antibodies were
produced, all antibodies used for the current study were
tested for cross-reactivity with BMP-6 (Fig. 1).
2.4. Cartilage extraction
Five hundred milligrams of fresh donor cartilage was
lyophilized overnight and the dry weight of the tissue was
determined. Samples were pulverized in liquid nitrogen and
150 mg (dry weight) of cartilage tissue was extracted with
3.5 ml of ice-cold 1 M GuHCl buffer, pH 7.5, containing 10
mM CaCl2, 50 mM Tris, and protease inhibitors (Protease
inhibitor cocktail tablets, one tablet per 10 ml of ice-cold 1
M GuHCl buffer; Roche Diagnostics, Indianapolis, IN). The
extraction was performed at 4 jC for 4 h with rotation.
Supernatants were centrifuged at 2500 rpm for 10 min at 4
jC, dialyzed for 2 days in water (12,000–14,000 MW
cutoff) and stored at 4 jC. To prove the efficiency of the
extraction, the cartilage tissue underwent a second extrac-
tion after the supernatants were removed. These extracts
were also analyzed by Western blotting and ELISA.
2.5. SDS-PAGE and Western blot analysis
2.5 mg dry weight of each sample (lyophilized) was
solubilized in a buffer containing 10 mM Tris, pH 6.5, 1%
SDS, 10% glycerol, 0.016% bromphenol blue. Samples were
loaded onto SDS-PAGE gel under reduced (with 2-mercap-
toethanol) or non-reduced conditions. Western blots were
performed following 12% SDS-PAGE gels. To reduce non-
specific binding, blots were incubated with blocking solution
containing 5% non-fat dry milk (Bio-Rad) in Tris-buffered
saline with 0.05% Tween 20 (TBS/Tween) (Bio-Rad) for 1 h
at room temperature. The blots were incubated with primary
antibody at suggested dilutions in TBS/Tween: 1:250 for
R2854 and MAB354 anti-OP-1 antibodies, and 1:100 for sc-
9305 antibody. As a secondary antibody, either ImmunoPure
goat anti-mouse IgG (Pierce, Rockford, IL) or donkey anti-
rabbit IgG (Pierce) conjugated with horseradish peroxidase
at 1:10,000 dilutions in TBS/Tween was used. The blots
were developed with the Enhanced Chemiluminescent
(ECL-Plus) kit for Western blotting (Amersham Pharmacia
Biotech, England). Specificity of the binding was compared
with the binding of the antibodies to recombinant pro- or
mature OP-1. Secondary antibodies were also tested for non-
specific binding. The densities of specific immunoreactive
bands was scanned by Fluor-S MultiImager (Bio-Rad) and
quantified by Quantity One Software program (Bio-Rad).
2.6. Chemiluminescent sandwich ELISA
For sandwich ELISA, two anti-OP-1 antibodies, poly-
clonal sc-9305 and monoclonal 1B12, were used. Polyclo-
nal anti-OP-1 antibody was utilized as a coating antibody.
Plates were coated with 50 ng/well of this antibody in TBS,
pH 7.5, and incubated overnight at 4 jC. Non-specific
binding was blocked with 200 Al/well blocking solution
(5% non fat dry milk in TBS/Tween, pH 7.5) for 2 h at room
temperature. To generate a standard curve, mature recombi-
nant OP-1 was diluted in TBS/Tween at different concen-
trations ranging from 10 to 0.01 ng/ml. Either OP-1 standard
(100 Al) or cartilage extract was added to the plate and
incubated for 1 h at room temperature. Second anti-OP-1
antibody (1B12) was applied at 1:1000 dilution in TBS/
Tween and incubated at room temperature for 1 h. Immu-
noPure goat anti-mouse IgG peroxidase conjugated anti-
body (Pierce) was used at 1:10,000 dilution as a secondary
antibody. The reaction was developed with Supersignal
ELISA Femto Maximum Sensitivity Substrate (Pierce).
Fig. 1. Specificity of different anti-OP-1 antibodies as detected by Western
blotting. (A) Anti-mature OP-1 antibody sc-9305 (Santa Cruz Biotechnol-
ogy); (B) anti-mature OP-1 antibody 1B12 (Stryker Biotech); (C) anti-pro-
OP-1 antibody R2854 (Stryker Biotech); (D) anti-mature OP-1 antibody
MAB354 (R&D Systems); (E) antibody that recognizes both BMP-6 and
BMP-7. Lane 1, recombinant BMP-6; Lane 2, recombinant BMP-7. A, B,
C, and E—proteins were loaded under non-reduced conditions; D—
proteins were reduced with 10% h-mercaptoethanol. Immunoreactive band
at 36 kDa corresponds to mature OP-1 dimer; band at 17 kDa corresponds
to mature OP-1 monomer; bands above 36 kDa correspond to the
aggregates of the recombinant proteins. These data prove the specificity of
the antibodies toward OP-1 protein.
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The data were obtained through chemiluminescent ELISA
plate reader Victor2 (Wallac) as relative light units (RLU).
2.7. Reverse transcription-polymerase chain reaction (RT-
PCR)
Total RNA was extracted directly from cartilage tissue
with acid-guanidinium thiocyanate as previously described
[36]. Specific primer pairs were constructed for OP-1 [31]
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
These primer pairs were designed to yield PCR products of
different sizes (319 base pairs [bp] for GAPDH and 313 bp
for OP-1). OP-1 primers used for nested RT-PCR: (a) 21-
mer, antisense, location 1810–1830, 5V-TTTTCCTTTCGC-
ACAGACACC-3V; (b) 20-mer, sense, location 1328–1347,
5V-TGCCATCTCCGTCCTCTACT-3V; and (c) 23-mer, sense,
location 1518–1540, 5V-TTCCCCTCCCTATCCCCAACTT-
T-3V. The specificity of the primers was previously proven
[31]. GAPDH primers were: sense, 5V-GGTATCGTGGAAG-
GACTCAT-3V and antisense, 5V-ACCACCTGGTGCTCA-
GTGTA-3V.Approximately1Agof totalRNAwas trans- cribed
using reverse transcriptase as described by Cs-Szabo et al.
[36]. Five microliters of the resulting cDNA was am-plified
byPCRusingTaqDNApolymerase (Promega,Madi-son,WI)
in the presence of specific upstream and down-stream primers
[15pMeach;primers (a) and(b) forOP-1gene]. 0.5microliters
of the first amplification product and a second sense primer
[primer (c); nested primer] was used for a subsequent ampli-
fication step. To perform RT-PCR at the optimal conditions
and to stay within the logarithmically linear product forma-
tion, 30 cycles were chosen (45 s at 95 jC, 30 s at 57 jC of
annealing temperature and 45 s at 72 jC for the primers used),
followed by the final extension for 5 min at 72 jC. PCR
products were separated in 3% Metaphor agarose gels (FMC
BioProducts, Rockland, ME) and visualized by ethidium
bromide staining. Densities of the bands weremeasured using
Fluor S MultiImager (Bio-Rad) with attached Quantity one
software program (Bio-Rad). The densities of the OP-1 bands
were normalized to the densities of the GAPDH bands to
control variability among samples.
2.8. Statistical analysis
All results shown are meanF S.D. of at least three
separate experiments, with triplicate determination for each
point. Covariation significance was determined by Pearson
correlation of normal data.
3. Results
3.1. Antibody specificity
For the current study, we have used either commercially
available antibodies or antibodies produced by Stryker Bio-
tech. Although the specificity of these antibodies was pre-
viously proven, we have tested their cross-reactivity to the
closely related member of the BMP family, BMP-6, of which
the recombinant form became recently available. As a pos-
itive control, human recombinant processed (mature) OP-1
dimer was used (molecular weight is 36 kDa for dimer and 17
kDa for the reduced monomer). It is important to mention that
with storage, recombinant OP-1 might form higher molecular
weight aggregates that could be detected by the antibodies as
a higher molecular weight band. In Fig. 1A–C, and E, BMP-6
and -7 were loaded onto the gels under non-reduced con-
ditions; while in Fig. 1D, these proteins were reduced with
10% h-mercaptoethanol. As shown in Fig. 1, anti-mature OP-
1 antibodies sc-9305 (Fig. 1A), 1B12 (Fig. 1B) andMAB354
(Fig. 1D) clearly recognized mature form of OP-1, both a
dimer (36 kDa) and a monomer (17 kDa); none of the
antibodies cross-reacted to BMP-6. Anti-pro-OP-1 antibody
R2854 (Fig. 1C) showed no specific binding neither to BMP-
6, nor to mature OP-1. As we showed previously [31], this
antibody reacts only with pro-domain of OP-1. As a control,
antibody that cross-reacts with both BMPs, BMP-6 and
BMP-7, is shown in Fig. 1E.
3.2. OP-1 ELISA method
To quantify antigenic endogenous OP-1 present in
tissue extracts and culture media, a sandwich ELISA
method has been developed. Several parameters have been
tested: different combinations of anti-OP-1 antibodies,
effect of pH, various extraction buffers, enzyme digestions,
normalization to the protein content or dry weight, etc. We
found that the highest sensitivity of the method was
achieved when the combination of polyclonal peptide
antibody sc-9305 (coating antibody) and monoclonal
1B12 antibody was used. Standard curves were originated
by utilizing human recombinant mature OP-1 at different
dilutions ranging from 0.01 to 10 ng/ml (Fig. 2). The
conformation of OP-1 epitope and therefore the sensitivity
of the method depend also on the pH of the buffer used for
ELISA. A wide range of pH values for TBS/Tween buffer
was tested (Fig. 3). Since the extraction buffer has a
neutral pH and at neutral pH the ELISA readings were
in the middle range, this pH was chosen as a standard for
OP-1 ELISA. To address the question of whether cartilage
extracts have to be dialyzed before the assessment by
ELISA, we have tested the effect of two extraction buffers
(1 M GuHCl and lysis buffer) on ELISA readings. As
shown in Fig. 4A, the presence of 1 M GuHCl buffer
inhibited the binding of OP-1 by 50% or more, while the
lysis buffer did not affect the ELISA results (Fig. 4B).
However, when the same cartilage specimens were
extracted with both buffers and then analyzed by ELISA,
we found that more antigenic OP-1 could be extracted
from cartilage tissue with GuHCl buffer than with lysis
buffer (Table 1). To overcome this problem, GuHCl buffer
was selected as an extraction buffer, and all samples had to
be dialyzed before further analysis.
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To standardize the ELISA method and to address the
possible decline in cell numbers and depletion of matrix
molecules that influence cartilage extractability with aging,
before extraction, 500 mg of tissue (wet weight) was always
lyophilized (to avoid the influence of matrix), pulverized in
liquid nitrogen and extracted with 1 M GuHCl in a ratio of
150 mg (dry weight) of tissue per 3.5 ml of buffer. A repeated
extraction of the remaining tissue with 4 M GuHCl buffer
showed no extractable OP-1 left as detected by ELISA. To
confirm quantitatively that 1 M GuHCl buffer extracts the
most of the antigenic OP-1, aliquots of the same cartilage
sample were extracted with a variety of extraction buffers
including: (1) 1 MGuHCl, 0.005M EDTA, 0.05MNaCl; (2)
50 mMTris, 1 MGuHCl; (3) 50 mMTris, 4 MGuHCl; (4) 50
mM Tris, 20 mMNa2HPO4; (5) 50 mM Tris, 1% SDS; (6) 50
mM Tris, 0.15 M h-mercaptoethanol; (7) 50 mM Tris, 0.1 M
NaCl, 8M urea; and (8) 50mMTris, 1MNaCl, 8M urea. The
choice of the dissociative/extraction agents was based on the
specifics of the extraction of BMPs and the ability of BMPs to
bind the components of cartilage extracellular matrix [19].
All these extracts were quantitatively analyzed by ELISA. 1
M GuHCl buffer was found to be the most appropriate for
OP-1 extraction from human adult articular cartilage.
While seeking the most sensitive ELISA conditions,
different enzymatic treatments of cartilage extracts were
performed. Cartilage extracts were treated for 1 h at 37 jC
with hyaluronidase (1 mg/ml), collagenase (5 mg/ml), chon-
droitinase ABC (0.1 U/ml), keratanase (0.1 U/ml), keratanase
II (0.001 U/ml) and combinations of these enzymes and
analyzed by ELISA. The values in the treatment groups were
compared to control groups (no prior digestion) (Table 1).We
found no significant differences between the groups in
ELISA readings. Therefore, enzymatic digestion is not
included in the standard protocol for ELISA. The high
sensitivity of this method was achieved by utilizing Chem-
iluminescent Supersignal ELISA Femto Maximum Sensitiv-
ity Substrate (Pierce).
3.3. Cartilage ELISA results
Extracts from all cartilage samples were analyzed with
the sandwich ELISA method described above. We found
that with increasing age, the content of endogenous OP-1
protein significantly declined ( p < 0.02; Fig. 5). Age of the
donors and the levels of OP-1 protein showed a significant
covariation (Pearson correlation, p< 0.02). Although carti-
lage samples were obtained from organ donors with no
history of joint disease, not all of them appeared to be
normal. It is noteworthy, that a decrease in the levels of OP-
1 protein with age was found not only in the group that
Fig. 3. Effect of pH of the TBS/Tween buffer on a standard curve generated by OP-1 sandwich ELISA.
Fig. 2. Typical standard curve with human recombinant OP-1 generated by chemiluminescent sandwich ELISA method.
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consisted of normal tissues and tissues exhibiting early
degenerative changes, but also in the subgroup of normal
cartilages only. When specimens with normal histomorpho-
logical appearance were secluded in a separate subgroup
and analyzed for the content of OP-1 protein, the same
statistical differences were detected (open circles for normal
cartilages only, Fig. 5).
3.4. Western Blot analysis
For Western blotting, representative samples were taken
from each age decade and analyzed with anti-mature OP-1
antibody. The gels were scanned and the densities of the
immunoreactive bands were measured. Two major OP-1
bands were present in all tested cartilages regardless of the
age of donors (Fig. 6A). These bands represented fully
processed mature OP-1 form (molecular weight is 36 kDa)
and the partially processed intermediate form of the OP-1
protein (molecular weight is 75 kDa). Semi-quantitative
densitometric analysis of each of the bands demonstrated
a decrease in the intensity of these bands with age, which
Fig. 5. Concentration of endogenous OP-1 protein detected by sandwich
ELISA method in extracts from all tested human adult articular cartilages
(solid squares) or in extracts from normal cartilages only (open circles).
Fig. 4. Effect of 1 M GuHCl extraction buffer (A) and lysis extraction
buffer (B) on a standard curve generated by OP-1 ELISA. Closed squares,
human recombinant OP-1 diluted in TBS/Tween buffer; opened circles,
human recombinant OP-1 diluted in lysis buffer.
Fig. 6. Changes in OP-1 protein with age detected by Western blotting. (A)
Representative Western blot with anti-mature OP-1 antibody of cartilage
extracts from each age decade. Band at 75 kDa indicates a hemidimer form
of OP-1 that consists of OP-1 mature dimer and one attached pro-domain
[35]; band at 36 kDa corresponds to the mature OP-1 dimer. (B) Semi-
quantitative image analyses of the Western blot described in A. Trendlines
indicate the changes in the intensity of the major OP-1 immunoreactive
bands.
Table 1
Effect of enzymatic digestion on the content of endogenous OP-1 in
extracts from the same cartilage specimen as detected by ELISA
(meanF S.D.)
Type of treatment ELISA (ng/ml)
1 M GuHCl buffer only 0.03F 0.0027
1 M GuHCl bufferFCHase, Ker, Ker II 0.027F 0.0019
1 M GuHCl bufferFCHase, Collagenase 0.022F 0.0024
1 M GuHCl bufferFHyaluronidase 0.025F 0.0027
1 M GuHCl bufferFCollagenase 0.0181F 0.0011
Lysis buffer 0.017F 0.0013
Lysis bufferFCHase, Collagenase 0.017F 0.0009
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correlated to ELISA findings (Fig. 6B). Western blot results
were normalized to tissue dry weight, as were ELISA data.
3.5. RT-PCR results
For PCR analysis, total RNAwas extracted directly from
cartilage tissue without previous chondrocyte isolation or
culture. Aliquots of the same mRNA were used for nested
RT-PCR with OP-1 and GAPDH specific primer sets. Both
PCR products were amplified with the same number of
cycles. GAPDH was chosen as the normalization factor,
since it is a housekeeping gene. We found that with aging
levels of GAPDH mRNA expression in normal cartilage did
not vary for more than 10%. As it was identified on the
protein level, OP-1 mRNA expression in articular cartilage
decreased with the increasing age of donors (Fig. 7;
p < 0.001).
4. Discussion
This study confirms an age-related decrease in the
anabolic activity of human adult articular cartilage. The
anabolic activity of cartilage was evaluated via the assess-
ment of changes in endogenous OP-1, a BMP that is
considered to be one of the most potent inducers of cartilage
regeneration and repair. We observed greater than a 4-fold
decline in OP-1 protein content between ages of 35 and 75
years. The data showed that there was a greater decline in
OP-1 mRNA expression, where in some cartilages from
older individuals, OP-1 message was barely detectable or
was below the detection limit. Another important result of
our study is that the concentration of endogenous OP-1
protein in normal articular cartilage is within the range of
biological activity of OP-1 (50–100 ng/ml) in vitro, as we
have shown previously [17,26–28].
One of the main difficulties in studying human tissue has
been to distinguish between non-pathologically (normal) and
pathologically progressive (degenerative) aging of articular
cartilage. The uniqueness of the present study lies in the
examination of age-related changes in human adult articular
cartilage obtained from normal individuals through the
collaboration with the Regional Organ Bank of Illinois in
Chicago. For this study, cartilage from organ donors with no
documented history of joint disease was selected. Although
tissue was collected from normal individuals (not from
patients), not all of the cartilages appeared normal. Some of
them displayed degenerative changes described in detail in
Chubinskaya et al. [37]. Therefore, tissue selected for the
current study was divided into two subgroups. One group
included the entire spectrum of cartilages, and one group
consisted only of normal cartilages (normal histomorpholog-
ical appearance). Critically, statistical changes in endogenous
OP-1 with age were observed in both groups, suggesting that
the decline in anabolic activity of human chondrocytes is
associated not only with degenerative changes, but is truly an
age-related process.
The decrease in endogenous OP-1 with aging of human
articular cartilage is consistent with previous findings on
changes in the levels of other growth factors and their
receptors, for example, a decrease in mRNA expression of
TGF-h1, 2 and 3 in aging equine articular cartilage [6] and
increase in EGF synthesis and a decrease in the EGF-
receptor mRNA by rat articular chondrocytes [4]. However,
our study is the first to show an age-related decrease in
endogenous OP-1 in human adult articular cartilage. Also,
in the current study, we evaluated changes in both levels,
message and protein, and found that there was a decrease in
OP-1 mRNA and protein expression with age.
Even though it is apparent that elderly people have
decreased levels of OP-1, it still remains unclear whether
this phenomenon is a result of aging per se or is due to other
age-related variables. The decrease in OP-1 protein in part
could be due to the suppression of mRNA expression (as we
demonstrated in this study), but also due to many other
processes including but not limiting a general slower meta-
bolic activity of older cells, increased degradation of OP-1
due to an activation of catabolic events in cartilage, increase
in OP-1 binding proteins, changes in OP-1 receptors or
other members of the BMP signaling pathway, etc.
Although degradation of OP-1 protein could be one of the
reasons in the decline of OP-1, we have not noticed an
accumulation of the degradation products in cartilage
matrix. As a consequence of aging, catabolic events could
be induced and different proteinases present in cartilage
could be activated leading to a degradation of a number of
matrix proteins including mature OP-1. Also mature OP-1
might undergo autodegradation and might be degraded by
serine proteinases.
The results obtained by Western blot analysis suggest that
the predominant form of OP-1 in cartilage is the intermediate
form (75 kDa), although some OP-1 is also present in the
mature (active) form (36 kDa). Since 75 kDa is a partially
processed form of OP-1 that contains in its structure one
bound pro-domain and one non-covalently associated pro-
domain in addition to two mature domains [35], we do not
Fig. 7. Graphical illustration of the changes in OP-1 mRNA expression with
aging of human adult articular cartilage. Semi-quantitative analysis of the
PCR bands. The levels of OP-1 message normalized to the levels of
GAPDH message. Solid squares represent all tested cartilage samples; open
circles represent a subgroup of normal cartilages.
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expect this form to be biologically active. By analogy to TGF-
h, pro-domain could function as a latency-associated protein
that prevents binding of mature BMP molecule to its recep-
tors [39]. However, the function of pro-domain is well
described only for TGF-h, and it remains unclear whether
pro-domain in other BMPs plays a similar role in preventing
the biological activity of these molecules.
The effect of binding proteins on endogenous OP-1
pathway in cartilage is largely unknown. If there is an
increase in BMP binding proteins with age as it is docu-
mented for IGF-1 binding proteins [38], the decline in OP-1
with age could be attributed by this phenomenon. The
exploration of OP-1 binding proteins in human adult artic-
ular cartilage and their effect on different cartilage matrix
molecules might shed the light on the entire OP-1/BMP
pathway role in aging and disease. As it was shown by
Martin et al. [38], an elevation of IGF binding proteins in rat
articular chondrocytes was one of the reasons for the
suppression of the synthetic activity of cells with age in
response to IGF-1. Also our preliminary experiments indi-
cate that BMP binding proteins added to cultures of human
articular chondrocytes suppress OP-1 and lead to a decline
in PG synthesis (unpublished data).
The results obtained in the present study confirm an age-
related decline in endogenous OP-1, one of the most potent
naturally occurring agents produced by chondrocytes that
could counteract cartilage destruction and/or facilitate its
repair. These data prompted us to develop a hypothesis that
a decrease in endogenous OP-1 metabolism with aging may
lead to an elevated susceptibility of cells to catabolic pro-
cesses thus contributing/promoting cartilage degeneration.
Further work is needed to confirm this hypothesis and to
understand the function of endogenous OP-1 in cartilage.
The availability of quantitative and qualitative methods
described here will provide necessary tools for answering
these and other questions and could be useful in monitoring
therapies and/or disease prognosis. The results of this study
suggest future means of using OP-1 to stimulate normal
phenotypic activity in articular chondrocytes and maintain/
restore function in affected joints.
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